Home - Products - Others - Other Targets - Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)

Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)

CAS No. ———

Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)( ——— )

Catalog No. M40947 CAS No. ———

Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)
  • Description
    Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    3870.52
  • Molecular Formula
    C171H254N4O16
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • L-838417 D9

    L-838417 is a novel deuterated subtype-selective GABAA positive allosteric modulator, acting as a partial agonist at α2, α3 and α5 subtypes.

  • Aristolactam FI

    Piperolactam A is a natural product that can be isolated from root of Piper betle. Piperolactam A exhibits promising leishmanicidal action against wild type and drug resistant strains of Leishmania donovani.

  • NNMTi

    NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.